PheRS Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PheRS Antibodies targeting phenylalanyltRNA synthetase (PheRS). PheRS Antibodies are effective tools in various research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PhenylalanyltRNA synthetase plays a crucial role in protein synthesis by catalyzing the attachment of phenylalanine to its corresponding tRNA, ensuring the accurate translation of genetic information into functional proteins. The enzyme maintains essential cellular metabolism functions and has significant implications in various diseases, making it an important focus of study in molecular biology and biochemistry. Understanding PheRS activity provides insights into fundamental cellular processes and potential therapeutic approaches. Researchers can utilize specific detection methods to examine PheRS expression patterns across different tissue types and cellular conditions. Advanced visualization techniques enable detailed analysis of PheRS localization and interactions within cellular compartments. The high-quality monoclonal antibodies from Santa Cruz Biotechnology support researchers worldwide in advancing scientific knowledge about phenylalanyltRNA synthetase and its impact on human health.